GLOW
GLOW

Home

/

Shop

/

GLOW

GLOW
GLOW
GLOW
GLOW
GLOW
GLOW

GLOW

£69.00Sold out
Out of stock
Size
1
ABOUT THIS COMPOUND
Description

The GLOW Blend from Super Human Peptides UK is an exceptionally powerful, multi-pathway tissue regeneration matrix. It combines three of the most heavily researched repair peptides into a single, synergistic lyophilized compound: BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg). In laboratory research, this specific ratio is utilized to study complete, top-to-bottom cellular rejuvenation.

While BPC-157 and TB-500 work systemically to up-regulate angiogenesis (new blood vessel formation) and drive cellular migration to deep structural injuries (muscle, tendon, and gut), the massive 50mg inclusion of GHK-Cu focuses heavily on the extracellular matrix. GHK-Cu is an endogenous copper complex that signals the breakdown of damaged scar tissue and stimulates the massive production of new collagen and elastin. Produced under GMP-compliant conditions and verified for 99% purity or higher, the GLOW blend is the ultimate preclinical model for investigating profound dermatological repair, structural healing, and systemic anti-aging.

Note: Due to the high concentration of the copper-binding peptide (GHK-Cu), the lyophilized powder and reconstituted solution will possess a natural, distinct blue tint.

WarningFor laboratory research use only. Not for human consumption.
Key Features
  • —Tri-Peptide Synergy: Targets tissue repair from three distinct biological pathways simultaneously.
  • —Deep Structural Repair: Utilizes BPC-157 and TB-500 for the rapid healing of muscle, tendon, and mucosal tissue.
  • —Extracellular Matrix Remodeling: The high-dose GHK-Cu component actively breaks down damaged collagen and replaces it with healthy, elastic tissue.
  • —Enhanced Angiogenesis: Creates massive networks of new blood vessels to deliver nutrients to regenerating cells.
  • —High Purity: 99% purity or higher across all three peptide chains (verified by HPLC and MS analysis).
  • —Quality Standard: GMP / ISO certified manufacturing.
Research Focus
  • —Synergistic Angiogenesis: Studying the overlapping mechanisms of BPC-157 (VEGFR2 activation) and TB-500 to exponentially increase capillary growth.
  • —Fibroblast Activation: Measuring the rapid influx of fibroblasts and the subsequent secretion of structural proteins (collagen and elastin) driven by GHK-Cu.
  • —Scar Tissue Degradation: Investigating the unique ability of copper peptides to modulate metalloproteinases, breaking down tough, fibrotic scar tissue.
  • —Tendon and Ligament Repair: Preclinical models exploring the accelerated healing of connective tissue via enhanced actin sequestration (TB-500) and tendon outgrowth (BPC-157).
  • —Dermatological Remodeling: Evaluating the thickening of the epidermis, reduction of photodamage, and restoration of skin elasticity.
Published Research and Study Findings

The GLOW blend represents the cutting edge of synergistic peptide research. Historically, these three peptides have been studied in isolation with profound results. Dr.

Loren Pickart discovered that GHK-Cu levels drop by over 60% as subjects age, leading directly to tissue breakdown and delayed healing. Restoring GHK-Cu in laboratory models proved to drastically up-regulate collagen production and skin repair. Simultaneously, researchers mapping BPC-157 and TB-500 demonstrated their ability to heal deep, severe systemic injuries.

When combined into a single matrix, laboratory models suggest a compounding effect. GHK-Cu signals the cleanup of damaged extracellular matrices; TB-500 physically alters the cellular cytoskeleton (via actin) to rush repair cells into the newly cleared area; and BPC-157 forms the vascular network necessary to keep those new cells alive. This tri-pathway approach makes it a premier focus for researching the reversal of severe biological decay and physical trauma.

NoteAll findings are derived from laboratory and non-clinical research settings.
Representative Scientific References
  • 1.Pickart, L. et al., "The human tripeptide GHK-Cu in prevention of oxidative stress and cognitive decline," Journal of Aging Research, 2012. (GHK-Cu).
  • 2.Sikiric, P. et al., "Novel cytoprotective mediator, gastric juice peptide BPC 157," European Journal of Pharmacology, 1999. (BPC-157).
  • 3.Philp, D. et al., "Thymosin beta4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair," Wound Repair and Regeneration, 2003. (TB-500).
  • 4.Pickart, L. et al., "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration," BioMed Research International, 2015.
Technical data
Specifications
Purity
≥99%, HPLC verified
Form
Lyophilised powder with blue colouration from copper content; 70mg blend (10mg BPC-157 / 50mg GHK-Cu / 10mg TB-500)
Molecular formula
See batch COA
Molecular weight
See batch COA
SKU
SHP-GLOW-070
Research category
Regeneration
Storage
-20°C, protected from light
Reconstitution
Reconstitute with bacteriostatic water; swirl gently, do not shake
Research use
In-vitro laboratory research only. Not for human consumption.
Common questions
Frequently asked questions
GLOW is a tri-peptide research blend containing 10mg BPC-157, 50mg GHK-Cu and 10mg TB-500 in a single 70mg vial. The powder is blue because of the copper in the GHK-Cu component.
It is used in wound healing, fibroblast activation, collagen synthesis and systemic cellular migration research, where all three repair mechanisms are examined in combination.
GLOW is supplied at ≥99% purity, verified by HPLC with mass-spectrometry identity confirmation. Testing is carried out per batch rather than per product line, so the figures on your certificate of analysis relate to the exact lot in your vial.
Store the sealed vial at -20°C, protected from light. Once reconstituted, the solution should be kept refrigerated at 2-8°C, protected from light, and treated as a short-lived working preparation rather than a long-term stock. The blue colour of the reconstituted solution reflects the copper content and is normal for this blend.
GLOW is supplied lyophilised. Reconstitute with bacteriostatic water; swirl gently, do not shake, and allow the powder to dissolve fully before use. Direct the solvent down the inside wall of the vial rather than onto the pellet, and record the volume used so working concentrations can be calculated. This applies to in-vitro laboratory work only.
GLOW is the same two peptides plus 50mg of GHK-Cu. That third component adds collagen synthesis and extracellular matrix remodelling to the angiogenesis and cell-migration mechanisms of the two-peptide mix, which makes GLOW the usual choice for dermatological and cosmetic research models.
Yes. A certificate of analysis covering HPLC purity and mass-spectrometry identity is available for every batch of GLOW. Each vial carries a batch number on its label, and quoting that number lets us send you the certificate that matches the material you hold rather than a generic example.
Exact mass data for GLOW is quoted on the certificate of analysis issued with the batch you receive, since figures vary slightly by production lot. Contact us before ordering if you need the values in advance.
GLOW ships from the UK to UK research addresses, with tracked dispatch and insulated packaging. It is sold for in-vitro laboratory research only: it is not a medicine, not a supplement, and not for human or veterinary consumption. Orders are accepted on the basis that the buyer is a qualified researcher.